Gold Rate

Nectar Lifesciences Ltd.

BSE: 532649 | NSE: NECLIFE |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.

Series: BE | ISIN: INE023H01027 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Nectar Lifesci Nectar Lifesciences Ltd. | BSE 13.64 0.14 (1.04%) | NSE 13.53 0.08 (0.59%) | Trade | Add

BSE Live

Feb 09, 12:16

13.64 0.14 (1.04%)

Volume

AVERAGE VOLUME

5-Day

69,576

10-Day

57,456

30-Day

63,907

16,909

Prev. Close

13.50
Open Price

13.74

Bid Price (Qty.)
13.51 (1500)
Offer Price (Qty.)
13.64 (100)

NSE Live

Feb 09, 12:16

13.53 0.08 (0.59%)

Volume

AVERAGE VOLUME

5-Day

220,077

10-Day

286,245

30-Day

424,506

93,460

Prev. Close

13.45
Open Price

13.46

Bid Price (Qty.)
13.59 (10)
Offer Price (Qty.)
13.61 (200)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Nectar Lifesciences (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	4.10	3.58	54.97	37.78	16.84
Diluted EPS (Rs.)	4.10	3.58	54.97	37.78	16.84
Cash EPS (Rs.)	5.84	5.58	67.84	45.01	21.98
Book Value [ExclRevalReserve]/Share (Rs.)	27.69	19.91	185.97	139.97	116.36
Book Value [InclRevalReserve]/Share (Rs.)	27.69	19.91	185.97	139.97	116.36
Dividend / Share(Rs.)	0.25	0.10	4.00	2.00	1.00
Revenue from Operations/Share (Rs.)	37.72	47.81	483.35	286.17	172.20
PBDIT/Share (Rs.)	9.54	9.56	90.91	61.39	32.38
PBIT/Share (Rs.)	7.81	7.58	78.21	54.38	27.44
PBT/Share (Rs.)	5.13	4.32	60.24	41.82	21.99
Net Profit/Share (Rs.)	4.10	3.58	54.97	37.78	16.84
Profitability Ratios
PBDIT Margin (%)	25.30	19.99	18.80	21.45	18.80
PBIT Margin (%)	20.71	15.84	16.18	19.00	15.93
PBT Margin (%)	13.59	9.03	12.46	14.61	12.76
Net Profit Margin (%)	10.87	7.49	11.37	13.20	9.77
Return on Networth / Equity (%)	14.81	18.00	29.56	26.99	14.46
Return on Capital Employed (%)	8.27	7.69	15.06	11.14	9.36
Return on Assets (%)	6.21	4.23	8.79	7.25	5.65
Total Debt/Equity (X)	0.97	2.32	1.71	2.03	0.86
Asset Turnover Ratio (%)	57.12	56.42	77.32	54.92	57.81
Liquidity Ratios
Current Ratio (X)	2.09	1.18	1.33	1.73	1.66
Quick Ratio (X)	1.02	0.58	0.82	1.00	1.01
Inventory Turnover Ratio (X)	2.13	2.08	3.69	2.17	2.25
Dividend Payout Ratio (NP) (%)	4.13	2.79	7.27	5.29	5.93
Dividend Payout Ratio (CP) (%)	2.90	1.79	5.89	4.44	4.55
Earnings Retention Ratio (%)	95.87	97.21	92.73	94.71	94.07
Cash Earnings Retention Ratio (%)	97.10	98.21	94.11	95.56	95.45
Valuation Ratios
Enterprise Value (Cr.)	1,382.20	841.14	764.18	600.84	517.77
EV/Net Operating Revenue (X)	1.63	1.16	1.04	1.41	2.02
EV/EBITDA (X)	6.46	5.78	5.52	6.57	10.74
MarketCap/Net Operating Revenue (X)	0.96	0.24	0.41	0.50	1.52
Retention Ratios (%)	95.86	97.20	92.72	94.70	94.06
Price/BV (X)	1.31	0.57	1.08	1.03	2.25
Price/Net Operating Revenue	0.96	0.24	0.41	0.50	1.52
Earnings Yield	0.11	0.32	0.27	0.26	0.06